Orikami is a Dutch MedTech organization. We are specialized in applied data science. We develop and implement digital biomarkers to enable personalized healthcare for people with chronic diseases.
Orikami is on a mission to improve 100 million lives before 2030 by enabling personalized healthcare.
We believe health data is underutilized. We use real-world patient data to enable personalized healthcare paths for our clients to improve their quality of life. Therefore, we develop digital biomarkers.
Our solutions deliver better outcomes and affordable healthcare.
Our services combine medical knowledge data science and academic approach.
This results in consultancy services and tailor-made digital medical devices for life science companies and healthcare providers.
What are digital biomarkers?
Digital biomarkers are defined as objective, quantifiable physiological and behavioral data. They are collected and measured by means of digital devices such as portables, wearables, implantables or digestibles.
Clinical validated digital biomarkers provide objective data that provides clinically significant results. This enables decision support.